Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

Conclusions In symptomatic patients following JJ-stent insertion, anti-muscarinic medication, namely solifenacin 5mg or trospium chloride 20mg, was the best. The advantage of trospium over solifenacin is in the control of frequency rather than the other symptoms. Addition of an α-blocker (alfuzosin 10mg) is valuable when nocturia is the predominant symptom.
Source: Arab Journal of Urology - Category: Urology & Nephrology Source Type: research